FDA Approves Lilly Breast Cancer Drug

23:44 EST 8 Nov 2017 | CHEManager

The US Food and Drug Administration has approved a new drug developed by Eli Lilly to treat a common type of breast cancer. Verzenio is recommended both for women and men with HR-positive, HER2-negative breast cancer that has worsened after hormone therapy. According to the regulator, some 72% of patients with breast cancer have this type.

Original Article: FDA Approves Lilly Breast Cancer Drug


More From BioPortfolio on "FDA Approves Lilly Breast Cancer Drug"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...